(Q37777541)

23 August 2017

1 reference

title

CD73: a novel target for cancer immunotherapy (English)

1 reference

23 August 2017

CD73: A Novel Target for Cancer Immunotherapy (English)

1 reference

10.1158/0008-5472.CAN-10-1544

Crossref

DOI

https://api.crossref.org/works/10.1158/0008-5472.CAN-10-1544

16 June 2024

1 reference

Bin Zhang

1

1 reference

23 August 2017

language of work or name

English

0 references

publication date

3 August 2010

1 reference

full work available at URL

23 August 2017

https://aacrjournals.org/cancerres/article-pdf/70/16/6407/2633826/6407.pdf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682793

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20682793/?tool=EBI

16 June 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682793

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20682793/pdf/?tool=EBI

16 June 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682793

http://cancerres.aacrjournals.org/cgi/content/abstract/70/16/6407

16 June 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682793

https://europepmc.org/articles/PMC2922475

16 June 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682793

https://europepmc.org/articles/PMC2922475?pdf=render

16 June 2024

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682793

https://doi.org/10.1158/0008-5472.can-10-1544

16 June 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682793

https://aacrjournals.org/cancerres/article-pdf/70/16/6407/2633826/6407.pdf

16 June 2024

1 reference

10.1158/0008-5472.CAN-10-1544

Crossref

DOI

https://api.crossref.org/works/10.1158/0008-5472.CAN-10-1544

16 June 2024

1 reference

23 August 2017

70

1 reference

23 August 2017

16

1 reference

23 August 2017

6407-6411

1 reference

T(H)17 cells in tumour immunity and immunotherapy.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922475

CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922475

Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922475

Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922475

Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922475

Hypoxia-adenosinergic immunosuppression: tumor protection by T regulatory cells and cancerous tissue hypoxia

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922475

Physiological roles for ecto-5'-nucleotidase (CD73).

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922475

Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review).

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922475

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922475

Immunosuppressive strategies that are mediated by tumor cells

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922475

T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5'-adenosine monophosphate to adenosine

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922475

A2A adenosine receptor protects tumors from antitumor T cells.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922475

Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922475

Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922475

Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922475

Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922475

Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922475

Tumor-promoting functions of adenosine

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922475

Ecto-enzyme and signaling functions of lymphocyte CD73

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922475

Adenosine acts through an A3 receptor to prevent the induction of murine anti-CD3-activated killer T cells.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922475

Ecto-5′-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells

1 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20682793

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20682793

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1158/0008-5472.CAN-10-1544

1 reference

23 August 2017

1 reference

23 August 2017

1 reference